Dr. Chris Vindurampulle is a senior associate with the intellectual property team in the firm's Melbourne office.
Chris' experience includes biotechnology, medical devices, pharmaceuticals, agri-technology, food products and processing, and simple mechanical technology.
He is registered to practice before the intellectual property offices of Australia and New Zealand. He is experienced in patent drafting, patent and trade mark prosecution and opposition, and freedom to operate, opinion and due diligence work.
He has gained broad and significant experience in relation with life science technologies including pharmaceuticals, biologics (eg antibodies, proteins and small molecules), medical devices, diagnostics, methods of medical treatment and prevention, agri-technology (transgenics, pesticides and machinery) and food-technology (products and processing technology). Additionally, Chris has experience with alloy design and production, metal casting and processing, and hydrocarbon processing.
Chris is a regular contributor to the research and startup sector, providing education and mentoring on the topics of identifying, protecting and leveraging intangible assets.
Prior to joining the firm, Chris was a senior associate at a boutique IP firm where he helped clients protect and leverage their intellectual property rights to achieve commercial success. Chris' focus has been broadly in life sciences.
Following his PhD, Chris was a postdoctoral research scientist where he developed and patented two key technologies related to vaccines.
Prior to transitioning to the IP profession, Chris obtained his PhD degree in microbiology and immunology, and subsequently spent six years as a postdoctoral researcher in vaccine development. During his research career, Chris authored numerous peer reviewed journal articles, and patented key vaccine technologies.
He also contributed to two Bill and Melinda Gates funded grand challenge projects.
- Inventor listed on granted U.S. Patents US 8,137,930 and US 8,076,130, and other corresponding foreign applications which are pending. US 8,137,930 has been the subject of a licensing agreement with an Indian biotech company.
- Employed as a researcher on two Bill and Melinda Gates funded Grand Challenges in Global Health initiatives.
- Author listed in nine scientific journal articles.
- Institute of Patent and Trademark Attorneys (Ordinary)
- Intellectual Property Society of Australia and New Zealand, member